Sustainable Growth Advisers LP Sells 763,968 Shares of The Cooper Companies, Inc. $COO

Sustainable Growth Advisers LP cut its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 18.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,368,567 shares of the medical device company’s stock after selling 763,968 shares during the period. Cooper Companies makes up approximately 1.9% of Sustainable Growth Advisers LP’s investment portfolio, making the stock its 21st largest holding. Sustainable Growth Advisers LP owned 1.72% of Cooper Companies worth $276,088,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Bell Investment Advisors Inc lifted its holdings in Cooper Companies by 106.3% during the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after acquiring an additional 219 shares in the last quarter. True Wealth Design LLC lifted its holdings in Cooper Companies by 484.8% during the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after acquiring an additional 383 shares in the last quarter. Cromwell Holdings LLC lifted its holdings in Cooper Companies by 128.8% during the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after acquiring an additional 273 shares in the last quarter. Board of the Pension Protection Fund bought a new position in Cooper Companies during the fourth quarter worth about $41,000. Finally, CYBER HORNET ETFs LLC bought a new position in Cooper Companies during the second quarter worth about $36,000. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Price Performance

NASDAQ:COO opened at $60.19 on Tuesday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. The stock’s 50-day simple moving average is $65.75 and its 200 day simple moving average is $74.81. The company has a market cap of $11.74 billion, a P/E ratio of 29.80, a P/E/G ratio of 1.58 and a beta of 0.88. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.Cooper Companies’s quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, sell-side analysts forecast that The Cooper Companies, Inc. will post 4.62 EPS for the current fiscal year.

Wall Street Analyst Weigh In

COO has been the topic of several recent research reports. Rothschild & Co Redburn downgraded Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target on the stock. in a research note on Wednesday, March 4th. Needham & Company LLC lifted their price target on Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research note on Friday, March 6th. Citigroup reissued a “neutral” rating and issued a $69.00 price target (down from $80.00) on shares of Cooper Companies in a research note on Thursday. Piper Sandler set a $86.00 price target on Cooper Companies and gave the company an “overweight” rating in a research note on Monday. Finally, Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $88.07.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.